Advertisement

Index by author

October 01, 1995; Volume 23,Issue 10

  1. Lau, S S

    1. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
      S S Lau, H E Kleiner and T J Monks
      Drug Metabolism and Disposition October 1995, 23 (10) 1136-1142;

  2. Leland, M

    1. Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.
      C B Davis, T W Hepburn, J J Urbanski, D C Kwok, T K Hart, D J Herzyk, S G Demuth, M Leland and G R Rhodes
      Drug Metabolism and Disposition October 1995, 23 (10) 1028-1036;

  3. Li, M

    1. Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.
      P A Crooks, M Li and L P Dwoskin
      Drug Metabolism and Disposition October 1995, 23 (10) 1175-1177;

  4. Lin, J H

    1. Species similarities and differences in pharmacokinetics.
      J H Lin
      Drug Metabolism and Disposition October 1995, 23 (10) 1008-1021;

  5. Luchetta, G

    1. Metabolism and pharmacokinetics of N1,N11-diethylnorspermine.
      R J Bergeron, W R Weimar, G Luchetta, R R Streiff, J Wiegand, J Perrin, K M Schreier, C Porter, G W Yao and H Dimova
      Drug Metabolism and Disposition October 1995, 23 (10) 1117-1125;

  6. Lunte, C E

    1. Microdialysis sampling for hepatic metabolism studies. Impact of microdialysis probe design and implantation technique on liver tissue.
      M I Davies and C E Lunte
      Drug Metabolism and Disposition October 1995, 23 (10) 1072-1079;
Back to top

In this issue

Advertisement